AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

AMILORIDE HYDROCHLORIDE

11 registrations across 2 African markets— 8 active

Markets with AMILORIDE HYDROCHLORIDE

🇿🇦South Africa
10 registrations
7 active
🇿🇼Zimbabwe
1 registration
1 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
AMILORIDE
TABLET; ORAL
🇿🇼ZimbabweCAPS PVT LTDactiveDec 2027
GSA-RETIC 5/50🇿🇦South AfricaAdcock Ingram LimitedsuspendedNov 2022
AMILCO*🇿🇦South AfricaTHE PREMIER PHARMACEUTICAL CO LTDsuspendedNov 2022
AQUADREX*🇿🇦South AfricaWARNER-LAMBERT SA (PTY) LTDsuspendedJun 2022
MERCK-AMILOZIDE🇿🇦South AfricaMERCK GENERICS RSA (PTY) LTDactiveJan 1900
BETARETIC🇿🇦South AfricaUnimed Healthcare (Pty) LtdactiveJan 1900
AMILORETIC🇿🇦South AfricaAdcock Ingram LimitedactiveJan 1900
SERVATRIN🇿🇦South AfricaPharmacare Limited û WoodmeadactiveJan 1900
ADCO-RETIC🇿🇦South AfricaAdcock Ingram LimitedactiveJan 1900
AMILORETIC H.S. TABLETS🇿🇦South AfricaAdcock Ingram LimitedactiveJan 1900
DEZRETIC🇿🇦South AfricaDezzo Trading 392 (Pty) LtdactiveJan 1900

AMILORIDE HYDROCHLORIDE in Africa — Regulatory Overview

AMILORIDE HYDROCHLORIDE is registered across 2 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Zimbabwe. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 8 (73%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.